CIK 0001159036
- Large accelerated filer
HALOZYME THERAPEUTICS, INC.
Sign in to watch- Ticker
- HALO
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 880488686
- Phone
- +1 858-794-8889
- Business address
- 12390 EL CAMINO REAL, SAN DIEGO, CA, 92130
- Former names
- HALOZYME THERAPEUTICS INC, GLOBAL YACHT SERVICES INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $21,662,139
- in 5 filings, $21.7M under 10b5-1 plans
Net −$21,662,139. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-12-14 | Torley Helen PRESIDENT AND CEO | Exercise or conversion · Option to Purchase Common Stock | −10,000 | $14.66 | $147K | 100,000 |
| 2022-12-13 | Torley Helen PRESIDENT AND CEO | Exercise or conversion | +10,000 | $14.66 | $147K | 597,177 |
| 2022-12-13 | Torley Helen PRESIDENT AND CEO | Sale | −9,507 | $58.64 | $557K | 587,670 |
| 2022-12-13 | Torley Helen PRESIDENT AND CEO | Sale | −493 | $59.12 | $29K | 587,177 |
| 2022-12-13 | Torley Helen PRESIDENT AND CEO | Exercise or conversion · Option to Purchase Common Stock | −10,000 | $14.66 | $147K | 110,000 |
| 2022-12-13 | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER | Sale | −4,935 | $58.67 | $290K | 158,202 |
| 2022-12-13 | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER | Sale | −5,065 | $58.66 | $297K | 153,137 |
| 2022-12-06 | Posard Matthew L. Director | Sale | −10,000 | $56.12 | $561K | 105,189 |
| 2022-12-05 | Posard Matthew L. Director | Sale | −10,000 | $55.74 | $557K | 115,189 |
| 2022-12-02 | Posard Matthew L. Director | Sale | −10,000 | $58.80 | $588K | 125,189 |
| 2022-11-17 | Torley Helen PRESIDENT AND CEO | Exercise or conversion | +10,000 | $14.66 | $147K | 597,177 |
| 2022-11-17 | Torley Helen PRESIDENT AND CEO | Sale | −10,000 | $52.15 | $521K | 587,177 |
| 2022-11-17 | Torley Helen PRESIDENT AND CEO | Exercise or conversion · Option to Purchase Common Stock | −10,000 | $14.66 | $147K | 120,000 |
| 2022-11-16 | MATSUI CONNIE Director | Gift | −9,250 | 178,939 | ||
| 2022-11-16 | Connaughton Bernadette Director | Gift | −5,998 | 32,221 | ||
| 2022-11-16 | Torley Helen PRESIDENT AND CEO | Exercise or conversion | +10,000 | $14.66 | $147K | 597,177 |
| 2022-11-16 | Torley Helen PRESIDENT AND CEO | Sale | −10,000 | $53.90 | $539K | 587,177 |
| 2022-11-16 | Torley Helen PRESIDENT AND CEO | Exercise or conversion · Option to Purchase Common Stock | −10,000 | $14.66 | $147K | 130,000 |
| 2022-11-15 | Torley Helen PRESIDENT AND CEO | Exercise or conversion | +10,000 | $14.66 | $147K | 597,177 |
| 2022-11-15 | Torley Helen PRESIDENT AND CEO | Sale | −9,987 | $54.11 | $540K | 587,190 |
Page 44 of 48 · 944 trades